Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension

Inclusion Criteria: * 18 - 85 years of age willing and able to give informed consent and in the investigator's judgment able to follow the study protocol * Ocular hypertension, primary open-angle glaucoma, pigmentary or pseudoexfoliation glaucoma, with mild to moderate glaucoma defined as Mean Deviation on Humphrey Visual Field testing no worse than -10 dB * Patients on latanoprost in the study eye with an adequate IOP control with latanoprost alone Exclusion Criteria: Systemic * Use of oral carbonic anhydrase inhibitors * Unstable dose of oral medication during the last 30 days that in the opinion of the Investigator may influence the IOP * Unstable dose of oral steroid at the time of enrollment * Use of immunosuppressants, immunomodulators, antimetabolites and/or alkylating agents within six months before screening or anticipated use at any time during the study * Known allergy or hypersensitivity to the study medication or its components * Female patients who are pregnant, nursing, or planning a pregnancy, or who are of childbearing potential and not using a reliable means of contraception * Participation in an investigational drug or device study within the 30 days before screening * Patient has a condition or is in a situation which, in the Investigator's opinion, may put the patient at significant risk, may confound the study results, or may interfere significantly with the patient's participation in the study * Any condition (including the inability to read visual …